Policy / Regulatory

NMPA Releases 109th RLD Catalog for Chemical Generics – 30 New Product Specifications Added, 24 Supplemented
GQCE testing

NMPA Releases 109th RLD Catalog for Chemical Generics – 30 New Product Specifications Added, 24 Supplemented

China's National Medical Products Administration (NMPA) released the 109th Catalog of Reference Listed Drugs for Chemical Generic Drugs, adding 30 new product specifications and supplementing information for 24 product specifications…

US Treasury Drafts China Pharma Investment Rules Likely to Preserve Licensing Deals – A Carve‑Out From Broader National‑Security Tightening

US Treasury Drafts China Pharma Investment Rules Likely to Preserve Licensing Deals – A Carve‑Out From Broader National‑Security Tightening

China's NHC Issues Landmark Rare‑Disease Notice – Mandating Province‑Wide Clinics and Quality Control Networks by End‑2026

China’s NHC Issues Landmark Rare‑Disease Notice – Mandating Province‑Wide Clinics and Quality Control Networks by End‑2026

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Contact US
NMPA Releases Updated List of Medical Devices Exempted from Clinical Evaluation
NMPA

NMPA Releases Updated List of Medical Devices Exempted from Clinical Evaluation

NMPA Releases 92nd Batch of Reference Drugs for Generic Quality Evaluation
GQCE testing

NMPA Releases 92nd Batch of Reference Drugs for Generic Quality Evaluation

Trump Executive Order Seeks to Align US Prescription Drug Prices with Global Standards
Trump tariffs

Trump Executive Order Seeks to Align US Prescription Drug Prices with Global Standards

Hainan Unveils 20 Measures to Boost Pharmaceutical Industry Reform and Quality
Boao Lecheng pilot zone

Hainan Unveils 20 Measures to Boost Pharmaceutical Industry Reform and Quality

Show More